Abstract
Asymptomatic renal stones are identified in 8–10% of screened populations. With the increasing utilization of CT, the number of patients seeking urologic care for incidentally diagnosed renal calculi is likely to increase. Such patients present an important management dilemma: differentiating those to treat surgically from those who can be safely observed. Observational studies have revealed that approximately 50% of asymptomatic stones will progress, but most will not require surgery. Stones >15 mm in diamater and located in the renal pelvis are at highest risk of progression. Although no guidelines exist for the optimal monitoring regimen for asymptomatic stones, follow-up studies may include serum creatinine, plain radiography, ultrasonography, and CT. Shock wave lithotripsy (SWL) does not seem to offer significant benefit over observation for asymptomatic calyceal stones. Percutaneous nephrolithotomy does improve stone-free rates compared to SWL or observation. Additional research is needed to characterize the role of ureteroscopic management of asymptomatic renal stones.
Key Points
-
The prevalence of asymptomatic stones identified in screened populations is 8–10%, and is likely to grow with increased CT utilization
-
Outcomes of asymptomatic stones <10 mm in diamater include a symptomatic stone event (13–32%), spontaneous passage (13–20%), size increase (30–46%) and intervention (7–26%)
-
Asymptomatic stones located in the renal pelvis and >15 mm are at high risk of progression, defined as increase in size, symptomatic stone event, or need for intervention
-
Shockwave lithotripsy does not improve stone-free rates or quality of life compared to observation for asymptomatic calyceal stones <15 mm
-
Percutaneous nephrolithotomy improves stone-free rates compared to shockwave lithotriposy and observation for asymptomatic lower pole stones
-
Randomized trials are needed to define the role of ureteroscopy in the management of asymptomatic renal stones
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson, C. M., Wilson, D. M., O'Fallon, W. M., Malek, R. S. & Kurland, L. T. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 16, 624–631 (1979).
Hiatt, R. A., Dales, L. G., Friedman, G. D. & Hunkeler, E. M. Frequency of urolithiasis in a prepaid medical care program. Am. J. Epidemiol. 115, 255–265 (1982).
Stamatelou, K. K., Francis, M. E., Jones, C. A., Nyberg, L. M. & Curhan, G. C. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 63, 1817–1823 (2003).
Scales, C. D. Jr et al. Changing gender prevalence of stone disease. J. Urol. 177, 979–982 (2007).
Pearle, M. S., Calhoun, E. A. & Curhan, G. C. Urologic diseases in America project: urolithiasis. J. Urol. 173, 848–857 (2005).
Brenner, D. J. & Hall, E. J. Computed tomography—an increasing source of radiation exposure. N. Engl. J. Med. 357, 2277–2284 (2007).
Berrington de Gonzalez, A. et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch. Intern. Med. 169, 2071–2077 (2009).
Boyce, C. J., Pickhardt, P. J., Lawrence, E. M., Kim, D. H. & Bruce, R. J. Prevalence of urolithiasis in asymptomatic adults: objective determination using low dose noncontrast computerized tomography. J. Urol. 183, 1017–1021 (2010).
Lorenz, E. C. et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol. Dial. Transplant. 26, 2695–2700 (2011).
Glowacki, L. S., Beecroft, M. L., Cook, R. J., Pahl, D. & Churchill, D. N. The natural history of asymptomatic urolithiasis. J. Urol. 147, 319–321 (1992).
Burgher, A., Beman, M., Holtzman, J. L. & Monga, M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J. Endourol. 18, 534–539 (2004).
Koh, L. T., Ng, F. C. & Ng, K. K. Outcomes of long-term follow-up of patients with conservative management of asymptomatic renal calculi. BJU Int. http://dx.doi.org/10.1111/j.1464-410X.2011.10329.x.
Inci, K. et al. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J. Urol. 177, 2189–2192 (2007).
Fine, J. K., Pak, C. Y. & Preminger, G. M. Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J. Urol. 153, 27–32; discussion 32–33 (1995).
El-Nahas, A. R., El-Assmy, A. M., Madbouly, K. & Sheir, K. Z. Predictors of clinical significance of residual fragments after extracorporeal shockwave lithotripsy for renal stones. J. Endourol. 20, 870–874 (2006).
Streem, S. B., Yost, A. & Mascha, E. Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J. Urol. 155, 1186–1190 (1996).
Raman, J. D. et al. Natural history of residual fragments following percutaneous nephrostolithotomy. J. Urol. 181, 1163–1168 (2009).
Ganpule, A. & Desai, M. Fate of residual stones after percutaneous nephrolithotomy: a critical analysis. J. Endourol. 23, 399–403 (2009).
Rebuck, D. A., Macejko, A., Bhalani, V., Ramos, P. & Nadler, R. B. The natural history of renal stone fragments following ureteroscopy. Urology 77, 564–568 (2011).
Kang, D. E. et al. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J. Urol. 177, 1785–1788; discussion 1788–1789 (2007).
Bandi, G., Best, S. L. & Nakada, S. Y. Current practice patterns in the management of upper urinary tract calculi in the north central United States. J. Endourol. 22, 631–636 (2008).
Skolarikos, A., Laguna, M. P., Alivizatos, G., Kural, A. R. & de la Rosette, J. J. The role for active monitoring in urinary stones: a systematic review. J. Endourol. 24, 923–930 (2010).
Goel, M. C., Ahlawat, R., Kumar, M. & Kapoor, R. Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention. J. Urol. 157, 1574–1577 (1997).
Bucuras, V. et al. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: nephrolithotomy in 189 patients with solitary kidneys. J. Endourol. http://dx.doi.org/10.1089/end.2011.0169.
Hyams, E. S., Winer, A. G. & Shah, O. Retrograde ureteral and renal access in patients with urinary diversion. Urology 74, 47–50 (2009).
Krambeck, A. E. et al. Management of nephrolithiasis after Cohen cross-trigonal and Glenn-Anderson advancement ureteroneocystostomy. J. Urol. 177, 174–178 (2007).
Dogan, H. S. & Tekgul, S. Management of pediatric stone disease. Curr. Urol. Rep. 8, 163–173 (2007).
Nelson, C. P. Extracorporeal shock wave lithotripsy in the pediatric population. Urol. Res. 38, 327–331 (2010).
Smaldone, M. C., Corcoran, A. T., Docimo, S. G. & Ost, M. C. Endourological management of pediatric stone disease: present status. J. Urol. 181, 17–28 (2009).
Raj, G. V., Bennett, R. T., Preminger, G. M., King, L. R. & Wiener, J. S. The incidence of nephrolithiasis in patients with spinal neural tube defects. J. Urol. 162, 1238–1242 (1999).
Stravodimos, K. G., Adamis, S., Tyritzis, S., Georgios, Z. & Constantinides, C. A. Renal transplant lithiasis: analysis of our series and review of the literature. J. Endourol. http://dx.doi.org/10.1089/end.2011.0049.
Strang, A. M., Lockhart, M. E., Amling, C. L., Kolettis, P. N. & Burns, J. R. Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J. Urol. 179, 832–836 (2008).
Rifaioglu, M. M., Berger, A. D., Pengune, W. & Stoller, M. L. Percutaneous management of stones in transplanted kidneys. Urology 72, 508–512 (2008).
Chu, D. I. & Freedland, S. J. Prostate cancer. Socioeconomic status and disparities in treatment patterns. Nat. Rev. Urol. 7, 480–481 (2010).
Fazel, R. et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N. Engl. J. Med. 361, 849–857 (2009).
Mancini, J. G. & Ferrandino, M. N. The impact of new methods of imaging on radiation dosage delivered to patients. Curr. Opin. Urol. 20, 163–168 (2010).
Zilberman, D. E. et al. Low dose computerized tomography for detection of urolithiasis—its effectiveness in the setting of the urology clinic. J. Urol. 185, 910–914 (2011).
Mermuys, K. et al. Digital tomosynthesis in the detection of urolithiasis: Diagnostic performance and dosimetry compared with digital radiography with MDCT as the reference standard. AJR Am. J. Roentgenol. 195, 161–167 (2010).
Keeley, F. X. Jr et al. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int. 87, 1–8 (2001).
Yuruk, E. et al. A prospective, randomized trial of management for asymptomatic lower pole calculi. J. Urol. 183, 1424–1428 (2010).
Albala, D. M. et al. Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results. J. Urol. 166, 2072–2080 (2001).
Pearle, M. S. et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J. Urol. 173, 2005–2009 (2005).
Bilgasem, S., Pace, K. T., Dyer, S. & Honey, R. J. Removal of asymptomatic ipsilateral renal stones following rigid ureteroscopy for ureteral stones. J. Endourol. 17, 397–400 (2003).
Preminger, G. M. Management of lower pole renal calculi: shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy. Urol. Res. 34, 108–111 (2006).
Author information
Authors and Affiliations
Contributions
Z. G. Goldsmith and M. E. Lipkin contributed equally to researching data for the article, discussion of content and reviewing the manuscript before submission. Z. G. Goldsmith wrote the article.
Corresponding author
Ethics declarations
Competing interests
M. E. Lipkin declares he has been a consultant for Boston Scientific. Z. G. Goldsmith declares no competing interests.
Rights and permissions
About this article
Cite this article
Goldsmith, Z., Lipkin, M. When (and how) to surgically treat asymptomatic renal stones. Nat Rev Urol 9, 315–320 (2012). https://doi.org/10.1038/nrurol.2012.43
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2012.43
This article is cited by
-
Residual fragment size following retrograde intrarenal surgery: a critical evaluation of related variables
Urolithiasis (2023)
-
Effects of metabolic syndrome on renal stone progression
World Journal of Urology (2022)
-
Is medical treatment necessary for infants with small urinary stones?
Urolithiasis (2021)
-
Determining the true burden of kidney stone disease
Nature Reviews Nephrology (2020)
-
Asymptomatic Renal Stones—to Treat or Not to Treat
Current Urology Reports (2018)